INHIBRX BIOSCIENCES, INC. — Income Charts
10 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-100.0% -$100K
$0
R&D↓-24.0% -$8M
$25M
D&A↓-18.1% -$125K
$564K
Operating Income
$-34M
EBITDA↓-18.1% -$125K
$564K
Interest Expense
$3M
Other Income/Expense
$2M
Pretax Income
$-35M
Tax Provision
$0
Net Income
$-35M
Operating Margin
-2106.8%
Net Margin
-2204.2%
Effective Tax Rate
0.0%
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
0.0%
Operating Lease Cost↓-68.8% -$2M
$1M
Revenue YoY Variation↓-100.0pts
-100.0%
Income YoY Variation↑+10.4pts
8.3%
Revenue QoQ Variation
-100.0%
Income QoQ Variation
-23.5%